Early lung adenocarcinoma
Conditions
Interventions
treatment group:fuzhengquxiefang
Sponsors
Department of Oncology of Shanghai Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients confirmed by pathology or cytology diagnosed as carcinoma in situ or with stage Ia non-small cell lung cancer; 2. Aged between 18 and 80 years (including 18, 80); 3. The expected survival period over 1 year; 4. Karnofsky score more than 60; 5. Before the treatment, the Chinese Traditional medicine pieces or granules were not used in 3 months; 6. Patients voluntary participation in this study, and can signed informed consent, and they can be followed up.
Exclusion criteria
Exclusion criteria: 1. Patients with severe disease, such as heart, liver and kidney, and its functional disorder; 2. Corticosteroids not used in the past 3 months; 3. Patients combined other immune disease; 4. 1 months after the chemotherapy or radiotherapy and chemotherapy and other cancer therapy are being conducted; 5. Pregnant or lactating women; 6. Patients cannot obey the rules of this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Routine blood test;CREA;BUN;ALT;AST;CK;CEA;CY-211;NSE;SCC;NK cells (CD3-CD56dimCD16+);B cells (CD19+);T cell subsets (CD3+CD4+CD8+);Treg (CD4+CD25+Foxp3+);MDSC(CD11b+ Gr-1+);recurrence rate;PFS;OS; | — |
Countries
China
Contacts
Public ContactLi Yan
Shanghai Traditional Chinese Medicine Hospital
Outcome results
None listed